ACIU - AC Immune SA
IEX Last Trade
2.81
0.010 0.356%
Share volume: 1,902
Last Updated: Fri 27 Dec 2024 08:29:21 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$2.80
0.01
0.36%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.77%
Return on assets
-3.59%
Return on sales
0%
Return on invested capital
127.06%
Total debt ratio
10.18%
Debt ratio change over timeo
-0.96%
Current Ratio
16.69%
Quick Ratio
0%
Cash Position Ratio
13.14%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-6.04%
Return on assets
-5.46%
Return on sales
0%
Return on invested capital
187.61%
Total debt ratio
8.53%
Debt ratio change over timeo
-0.97%
Current Ratio
19.18%
Quick Ratio
0%
Cash Position Ratio
12.83%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.13%
Return on assets
-7.51%
Return on sales
0%
Return on invested capital
242.4%
Total debt ratio
9.11%
Debt ratio change over time
-0.96%
Current Ratio
18.1%
Quick Ratio
0%
Cash Position Ratio
12.75%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.97%
Return on assets
-100.24%
Return on sales
0%
Return on invested capital
-76.51%
Total debt ratio
-96.34%
Debt ratio change over time
-0.96%
Current Ratio
5.44%
Quick Ratio
0%
Cash Position Ratio
3.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACIU | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.77% | -3.65% | 12.3% | 6.42% |
| Return on assets | -3.59% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 127.06% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 61% |
| Total debt ratio | 10.18% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.96% | 224.03% | 6.03% | 1.46% |
| Dept financing | 3% | 50% | 19% | 8% |
| Current Ratio | 19.18% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 12.83% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 14% | 31% | 32% |
| Short-term ratios | ACIU | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.04% | -16.17% | 18.05% | 7.63% |
| Return on assets | -5.46% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 187.61% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 69% | 63% |
| Total debt ratio | 8.53% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.97% | 851.68% | 10.97% | 0.58% |
| Dept financing | 2% | 50% | 21% | 8% |
| Current Ratio | 19.18% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 12.83% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 22% | 17% | 32% |